Adam Lessler

Adam Lessler joined Evidity in 2015.
He is a licensed physician with residency training in emergency medicine and over a decade of healthcare industry experience counseling Boards and senior leadership teams.
Prior to joining Evidity, Adam was an engagement manager at McKinsey & Company, where he served clients across the health care value chain, with a focus on provider growth and M&A/partnership strategy.
Previously, Adam completed his internship in emergency medicine at the Hospital of the University of Pennsylvania and worked as an analyst in the Investment Banking Division at Goldman Sachs and as a research assistant in Harvard Medical School’s Department of Health Care Policy.
Adam sits on the Board of Directors of Standard Molecular, and he is a board observer at Magnolia Medical Technologies, PreludeDx and Sonde Health.
Adam has a B.A.
in economics from Amherst College, an M.B.A.
from the Wharton School of the University of Pennsylvania, and an M.D.
from the Perelman School of Medicine at the University of Pennsylvania.